GSK plc Reports Share Transactions
Ticker: GLAXF · Form: 6-K · Filed: Aug 5, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Aug 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-transaction, sec-filing, disclosure
TL;DR
GSK plc filed a 6-K on Aug 5, 2025, detailing transactions in its own shares.
AI Summary
GSK plc announced a transaction in its own shares on August 5, 2025. The company, formerly known as GlaxoSmithKline PLC, is filing a Form 6-K report with the SEC, indicating it will file annual reports under Form 20-F. The filing details are related to transactions in the company's own shares.
Why It Matters
This filing provides transparency on GSK's activities related to its own stock, which can be relevant for investors monitoring share buybacks or issuances.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of share transactions and does not indicate any immediate financial distress or significant new risks.
Key Players & Entities
- GSK plc (company) — Registrant
- GlaxoSmithKline PLC (company) — Former company name
- August 5, 2025 (date) — Filing date
- Form 6-K (document) — Filing type
- Form 20-F (document) — Annual report filing
FAQ
What type of report is GSK plc filing?
GSK plc is filing a Form 6-K report.
What is the filing date of this report?
The filing date is August 5, 2025.
What is the primary subject of this Form 6-K filing?
The filing pertains to a 'Transaction in own shares'.
What is GSK plc's former name?
GSK plc was formerly known as GlaxoSmithKline PLC.
Under which form does GSK plc file its annual reports?
GSK plc indicates it files its annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on August 5, 2025 regarding GSK plc (GLAXF).